UnitedHealth Group’s (NYSE: UNH) stock has fallen significantly, dropping from approximately $600 in April 2023 to around $275 in May, before recovering to $325. This decline was prompted by disappointing Q1 earnings results, a withdrawal of the company’s earnings outlook, and sudden management changes.
As of July 1, 2025, UnitedHealth’s market capitalization is $297 billion, with a debt of $81 billion, resulting in a debt-to-equity ratio of 28.6%. Recent revenue growth shows an average increase of 11.3% over the past three years, significantly outperforming the S&P 500’s 5.5% increase. Additionally, the price-to-sales ratio for UnitedHealth stands at 0.7, compared to the S&P 500’s 3.1, indicating a more attractive valuation.
In terms of profitability, UnitedHealth reported an operating income of $33 billion, marking an operating margin of 8.2% over the last four quarters. Despite lower profit margins compared to peers, the company maintains a strong cash-to-assets ratio of 11.1%, highlighting its financial stability amid recent market volatility.
